ArrayExpress Uploader0mouse8 weekswild type FVB mouse whole mammary glandwhole mammary gland tissue8 weekswild type FVB mouse whole mammary glandwhole mammary gland tissue8 weekswild type FVB mouse whole mammary glandwhole mammary gland tissue8 weekswild type FVB mouse whole mammary glandwhole mammary gland tissue8 weekswild type FVB mouse whole mammary glandwhole mammary gland tissue8 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor8 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor8 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor8 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor8 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor12 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor12 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor12 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor12 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor12 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor16 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor16 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor16 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor16 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor16 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor20 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor20 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor20 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor20 weekstransgenic FVB C3(1)-SV40Tag mouse whole mammary glandmammary tumor7427arrayexpress_sid6Silencing HoxA1 in vivo by intraductal delivery of nanoparticle-formulated siRNA reduced mammary tumor incidence by 75% , reduced cell...E-GEOD-50813/profile/8773/arrayexpressuploader324cellglandmammary tumorDec.12, 2014Falseprevention-of-mammary-tumor-progression-by-silenciE-GEOD-50813_A-AFFY-45Prevention of mammary tumor progression by silencing HoxA1 via intraductal injection of nanoparticle-formulated siRNANov.12, 2014Silencing HoxA1 in vivo by intraductal delivery of nanoparticle-formulated siRNA reduced mammary tumor incidence by 75% , reduced cell proliferation, and prevented loss of ER and PR expression. 8 week wild type FVB mouse whole mammary gland and 8week to 20 week transgenic FVB C3(1)-SV40Tag mouse whole mammary glandhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50813http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-50813/samples/